Imiquimod, a Toll-like receptor 7 agonist, inhibits melanogenesis and proliferation of human melanocytes.
Kang
Hee Young
HY
Park
Tae Jun
TJ
Jin
Sun Hee
SH
D000276:Adjuvants, Immunologic / Q000494:pharmacology; D000634:Aminoquinolines / Q000494:pharmacology*; D015153:Blotting, Western; D049109:Cell Proliferation / Q000187:drug effects; D002478:Cells, Cultured; D005786:Gene Expression Regulation; D006801:Humans; D000077271:Imiquimod; D007150:Immunohistochemistry; D008544:Melanocytes / Q000378:metabolism*; D008954:Models, Biological; D020133:Reverse Transcriptase Polymerase Chain Reaction; D012867:Skin / Q000187:drug effects* / Q000378:metabolism; D051199:Toll-Like Receptor 7 / Q000819:agonists*
D000276:Adjuvants, Immunologic; D000634:Aminoquinolines; C495348:TLR7 protein, human; D051199:Toll-Like Receptor 7; D000077271:Imiquimod